HCA vs MAZE · P/E 17, rev $75.60B vs rev $20.0M
HCA Holdings Inc (HCA) versus Maze Therapeutics, Inc. Common Stock (MAZE) — a side-by-side from cached financials, not a winner call.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Latest reported MAZE revenue for 2026-06-30 was $20.0M. Net income was -$68.9M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. MAZE currently screens at market cap $525.3M.
HCA currently screens at market cap $91.01B and trailing P/E 16.8. MAZE currently screens at market cap $525.3M.
Not investment advice. Open the HCA and MAZE stock pages for the full models.
Not investment advice.